Adli Abouzeedan and Maureen McKelvey, University of Gothenburg, Sweden
Purpose: The purpose of this paper is to present and analyse the strategies used in building the Swedish biotechnology sector. Developing as well as developed countries need access to a strong and vitalised biotechnology industry for their economic and social progress. In Sweden, the biotechnology sector is playing an important role in regional and national economic development and growth. This can serve as an example of trends in other developed countries.
Design/methodology/approach: This paper discusses alternative business models and the setting of the industry, which has traditionally been highly dependent upon basic research, but also upon demand and markets. We then use this analysis to draw out general lessons and recommendations that may assist the Arab countries in their efforts to build a sustainable biotechnology sector, with focus on health and medical applications.
Practical implications: The findings offer valuable knowledge for use in developing the biotechnology sector in the Arab world.
Findings: Our analysis, showed that in order to use the Swedish biotechnology model in the Arab world, the additive solution should be used in accordance with the IBAM. This means engaging the whole region in the process rather than focusing on single countries.
Originality/value: We hope that this work provides strategies for Arab planners in transferring the guided experiences of other nations into their countries.
Keywords: Sustainable development; Biotechnology; Pharmaceutical industry; Healthcare; Business models; System capital; Innovation capital; MENA; Arab world; Arab Spring; Innovation Balance Matrix; IBAM